Bristol Myers Squibb is reimagining the future of cell therapy, with a bold ambition and a commitment to unlock the full promise of cell therapy. The BMS Cell Therapy Development Organization (CTDO) is developing novel cellular immunotherapies based on Chimeric Antigen Receptors (CARs) and T Cell Receptors (TCRs) technologies. The company is looking for a Manager / Senior Engineer to join the Breyanzi Product Stewardship Cell Therapy Technical Operation (CTTO) department, responsible for implementing cell therapy manufacturing technologies and process changes related to the life-cycle management of a commercial CAR-T Therapy. This role involves establishing strategies for process changes, coordinating technical alignment, and leading implementation at a global level, collaborating across all CMC functional areas and drug product manufacturing sites.